Advertisement

Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81
Organisation › Details

Biodesix Inc.

Biodesix is a lung cancer diagnostic solutions company addressing the continuum of patient care from early diagnosis of lung nodules through late stage cancer. The company develops diagnostic tests addressing important clinical questions by combining simple blood draws and multi-omics with the power of artificial intelligence. Biodesix is the first company to offer three best-in class tests for patients with lung cancer, and multiple pipeline tests including one with the potential to identify patients who may benefit from immunotherapies. The Biodesix Lung Reflex® strategy integrates the GeneStrat® and VeriStrat® tests to support treatment decisions with results in 72 hours. The Nodify XL2™ nodule test, which will be commercially available in the second half of 2019, evaluates the risk of malignancy, enabling physicians to triage patients to the most appropriate course of action. Biodesix also partners with the world’s leading biotechnology and pharmaceutical companies to solve complex diagnostic challenges. *

 

Period Start 2005-01-01 established
Products Industry molecular diagnostics
  Industry 2 MALDI-TOF mass spectrometry technology
Persons Person Brunel, David (Biodesix 200810 CEO)
  Person 2 Hutton, Scott (Biodesix 201803– COO before Spectranetics + Medtronic)
     
Region Region Boulder, CO
  Country United States (USA)
  Street 2970 Wilderness Place
Suite 100
  City 80301 Boulder, CO
  Tel +1-303-417-0500
    Address record changed: 2018-07-24
     
Basic data Employees D: 101 to 500 (2015-10-09)
     
    * Document for �About Section�: Oncimmune Holdings plc. (6/28/19). "Press Release: Oncimmune Secures Strategic Commercialisation Agreement for EarlyCDT Lung in the US with Biodesix, Inc.". London.
     
   
Record changed: 2019-06-29

Advertisement

Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81

More documents for Biodesix Inc.


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture [iito] Männer Ballett 650x80px




» top